Literature DB >> 26732593

Close Encounters of the First Kind: Innate Sensors and Multiple Sclerosis.

Lidia Fernández-Paredes1, Rebeca Pérez de Diego2, Clara de Andrés3, Silvia Sánchez-Ramón4,5.   

Abstract

Although autoimmune diseases by definition imply adaptive immune system pathologies, growing evidence points to the relevance of innate receptors in modulating the initiation and progression of the autoreactive response. Multiple sclerosis (MS) is a chronic autoimmune disease characterised by central nervous system (CNS) demyelination, inflammation and axonal damage, in which the role of several pathogens such as herpes viruses have long been described as potential triggers. Encounters of these pathogens with altered innate receptors in susceptible individuals might drive pathological autoreactivity and inflammation, overcoming tolerance and causing subsequent CNS damage. In particular, functional and genetic studies reveal that Toll-like receptor (TLR) 2 and the Nod-like receptor (NLR) P3 could be involved in MS pathogenesis, whereas TLR3, the triggering receptor expressed on myeloid cells (TREM)-2 and the C-type lectin receptors (CLRs) MBL and MASP-3 would have a putative protective role. A better understanding of these interactions will provide important insights into the aetiopathogenesis of MS and could help design potential targets for novel therapies.

Entities:  

Keywords:  Dysregulation; Infectious; Innate immunity; Multiple sclerosis; Pathogen-associated molecular patterns (PAMPs); Pattern recognition receptors (PRRs)

Mesh:

Substances:

Year:  2016        PMID: 26732593     DOI: 10.1007/s12035-015-9665-5

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  132 in total

1.  TLR2 engagement on CD8 T cells enables generation of functional memory cells in response to a suboptimal TCR signal.

Authors:  Blandine C Mercier; Anne Cottalorda; Charles-Antoine Coupet; Jacqueline Marvel; Nathalie Bonnefoy-Bérard
Journal:  J Immunol       Date:  2009-02-15       Impact factor: 5.422

Review 2.  Environmental factors in multiple sclerosis.

Authors:  Alberto Ascherio
Journal:  Expert Rev Neurother       Date:  2013-12       Impact factor: 4.618

3.  Toll-like receptor 3 differently modulates inflammation in progressive or benign multiple sclerosis.

Authors:  Marina Saresella; Andrea Gatti; Paola Tortorella; Ivana Marventano; Federica Piancone; Francesca La Rosa; Domenico Caputo; Marco Rovaris; Mara Biasin; Mario Clerici
Journal:  Clin Immunol       Date:  2013-11-05       Impact factor: 3.969

4.  Interferon-β inhibits toll-like receptor 9 processing in multiple sclerosis.

Authors:  Konstantin E Balashov; Latt Latt Aung; Adi Vaknin-Dembinsky; Suhayl Dhib-Jalbut; Howard L Weiner
Journal:  Ann Neurol       Date:  2010-12       Impact factor: 10.422

5.  Initiation and progression of axonopathy in experimental autoimmune encephalomyelitis.

Authors:  Athena M Soulika; Eunyoung Lee; Erica McCauley; Laird Miers; Peter Bannerman; David Pleasure
Journal:  J Neurosci       Date:  2009-11-25       Impact factor: 6.167

6.  Identification of soluble TREM-2 in the cerebrospinal fluid and its association with multiple sclerosis and CNS inflammation.

Authors:  Laura Piccio; Cecilia Buonsanti; Marina Cella; Ilaria Tassi; Robert E Schmidt; Chiara Fenoglio; John Rinker; Robert T Naismith; Paola Panina-Bordignon; Nadia Passini; Daniela Galimberti; Elio Scarpini; Marco Colonna; Anne H Cross
Journal:  Brain       Date:  2008-09-12       Impact factor: 13.501

7.  Pivotal advance: HMGB1 expression in active lesions of human and experimental multiple sclerosis.

Authors:  Asa Andersson; Ruxandra Covacu; Dan Sunnemark; Alexandre I Danilov; Assunta Dal Bianco; Mohsen Khademi; Erik Wallström; Anna Lobell; Lou Brundin; Hans Lassmann; Robert A Harris
Journal:  J Leukoc Biol       Date:  2008-07-21       Impact factor: 4.962

8.  Double-stranded RNA mediates interferon regulatory factor 3 activation and interleukin-6 production by engaging Toll-like receptor 3 in human brain astrocytes.

Authors:  Hyemi Kim; Eunjung Yang; Jeonggi Lee; Se-Hoon Kim; Jeon-Soo Shin; Joo Young Park; Sun Ju Choi; Se Jong Kim; In-Hong Choi
Journal:  Immunology       Date:  2008-01-31       Impact factor: 7.397

9.  I-kappa-kinase-2 (IKK-2) inhibition potentiates vincristine cytotoxicity in non-Hodgkin's lymphoma.

Authors:  Ayad Al-Katib; Alan A Arnold; Amro Aboukameel; Angela Sosin; Peter Smith; Anwar N Mohamed; Frances W Beck; Ramzi M Mohammad
Journal:  Mol Cancer       Date:  2010-09-01       Impact factor: 27.401

10.  Varicella zoster virus and relapsing remitting multiple sclerosis.

Authors:  Julio Sotelo; Teresa Corona
Journal:  Mult Scler Int       Date:  2011-03-30
View more
  3 in total

1.  Alterations of the human gut microbiome in multiple sclerosis.

Authors:  Sushrut Jangi; Roopali Gandhi; Laura M Cox; Ning Li; Felipe von Glehn; Raymond Yan; Bonny Patel; Maria Antonietta Mazzola; Shirong Liu; Bonnie L Glanz; Sandra Cook; Stephanie Tankou; Fiona Stuart; Kirsy Melo; Parham Nejad; Kathleen Smith; Begüm D Topçuolu; James Holden; Pia Kivisäkk; Tanuja Chitnis; Philip L De Jager; Francisco J Quintana; Georg K Gerber; Lynn Bry; Howard L Weiner
Journal:  Nat Commun       Date:  2016-06-28       Impact factor: 14.919

2.  Programmed cell death and natural killer cells in multiple sclerosis: new potential therapeutic targets?

Authors:  Beatrice Macchi; Antonio Mastino
Journal:  Neural Regen Res       Date:  2016-05       Impact factor: 5.135

3.  Altered Levels of Toll-Like Receptors in Circulating Extracellular Vesicles in Multiple Sclerosis.

Authors:  Pavan Bhargava; Carlos Nogueras-Ortiz; Sahil Chawla; Rikke Bæk; Malene Møller Jørgensen; Dimitrios Kapogiannis
Journal:  Cells       Date:  2019-09-10       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.